πŸ‡ΊπŸ‡Έ FDA
Patent

US 10280171

Heterocyclic inhibitors of PTPN11

granted A61KA61K31/4985A61K31/501

Quick answer

US patent 10280171 (Heterocyclic inhibitors of PTPN11) held by The Board of Regents of the University of Texas System expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/4985, A61K31/501, A61P, A61P35/00